業績集 1999
2011 | 2010 |
2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993
1 | Nishimura Y., Yokoe Y., Nagata Y., Okajima K., Nishida M. and Hiraoka M.: High-dose-rate brachytherapy using molds for oralcavity cancer., Int. J. Clin. Oncol., 3: 351-56, 1998 |
|
2 | Teshima T., Ikeda H., Abe M., Hanks G.E., Owen J.B., Oguchi M., Hirokawa Y., Hiraoka M., Nishio M., Yamashita T., Naito A., Okazaki Y., Inoue T.: Patterns of care study of radiation therapy for utereine cervix cancer in Japan: The influence of age on the process., Int. J. Clin. Oncol., 4: 9-16, 1999 |
|
3 | Yamamoto M., Nagata Y., Okajima K., Ishigaki T., Murata R., Mizowaki T., Kokubo M. and Hiraoka M.: Differences in target outline delineation from CT scans of brain tumours using different methods and different observers., Radiother. Oncol., 50(2):151-56, 1999 |
|
4 | Nagata Y., Okajima K., Kokubo M., Kanamori S., Fujiwara K., Mizowaki T., Sasai K., Hiraoka M., Kataoka N., Konishi I.: Clinical results of transcatheter arterial infusion for uterine cervical cancer., Am. J. Clin. Oncol., 22(1): 97-102, 1999 |
|
5 | Tanisada K., Teshima T., Inoue T., Owen J.B., Hanks G.E., Abe M., Ikeda H., Sato S., Kawachi K., Yamashita T., Nishio M., Hiraoka M., Hirokawa Y., Oguchi M. and Masuda K.: National average for the process of radiation therapy in Japan by Patterns of Care Study., Jpn. J. Clin. Oncol., 29(4): 209-13, 1999 |
|
6 | Kanamori S., Nishimura Y., Kokubo M., Sasai K., Hiraoka M., Shibamoto Y., Hosotani R., Imamura M., Abe M.: Tumor response and patterns of failure following intraoperative radiotherapy for unresectable pancreatic cancer; Evaluation by computed tomography., Acta Oncolologica, 38(2): 215-20, 1999 |
|
7 | Ishikawa S., Nagata Y., Mitsumori M., Sasai K., Kokubo M., Hiraoka M., Tanaka T., Fukumoto M.: Primary large cell carcinoma of the submandibular gland., Int. J. Clin. Oncol., 4: 189-92, 1999 |
|
8 | Shibamoto Y., Sasai K., Oya N., Hiraoka M.: Systemic chemotherapy with vincristine, cyclophophamide, doxorubicin and predonisolone following radiotherapy for primary central nervous system lymphoma: a phase II study., J. Neuro-oncol., 42(2): 161-67, 1999 |
|
9 | Kanamori S., Nishimura Y., Okuno Y., Horii N., Saga T., Hiraoka M.: Induction of vascular endothelial growth factor (VEGF) by hyperthermia and/or an angiogenesis inhibitor., Int. J. of Hyperthermia, 15(4): 267-78, 1999 |
|
10 | Okuno Y., Nishimura Y., Kashu I., Ono K., Hiraoka M.: Prognostic values of proliferating cell nuclear antigen(PCNA) and LI-67 for radiotherapy of esophageal squamous cell carcinomas., Brit. J. Cancer, 80(3-4): 387-95, 1999 |
|
11 | Guo G.Z., Sasai K., Oya N., Shibata T., Shibuya K., Hiraoka M.: A significant correlation between clonogenic radiosensitivity and the simultaneous assessment of micronucleus and apoptotic cell frequencies., Int. J. Radiat. Biol., 75(7): 857-864, 1999 |
|
12 | Nishimura Y., Okuno Y., Ono K., Nagata Y., Hiraoka M.: External beam radiation therapy with or without high-dose-rate intraluminal brachytherapy for patients with superficial esophageal carcinoma., Cancer, 86(2): 220-28, 1999 |
|
13 | Saitoh H., Nagata Y., Mitsumori M., Kokubo M. and Hiraoka M.: Angiographic changes in uterine cervical cancer guring the course of transarterial infusion chemotherapy., Radiat. Medicine, 17(4): 305-9, 1999 |
|
14 | Shibuya K., Sasai K., Xie X., Utsumi H., Shibata T., Hiraoka M.: Detection of hypoxic cells inmurine tumors using the comet assay: comparison with a conventional radiobiological assay., Jpn. J. Cancer Res., 90(8): 880-86, 1999 |
|
15 | Mitsumori M., Hiraoka M., Kodama H.: Long-term results of postoperative prophylactic irradiation for node-positive, high-risk breast cancer patients., Breast Cancer, 6(3): 193-200, 1999 |
|
16 | Shibuya K., Fujibayashi Y., Yoshimi E., Sasai K., Hiraoka M., Welch M.J.: Cytosolic/microsomal redox pathway: a reductive retention mechanism of a PET-oncology tracer, Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (Cu-PTSM)., Ann. Nucl. Med., 13(5): 287-92, 1999 |
|
17 | Shibamoto Y., Sasai K., Kokubo M., Hiraoka M.: Salvage radiation therapy for intracranial germinoma recurring after primary chemotherapy., J. Neuro-Oncol., 44(2):181-85, 1999 |
|
18 | Higashi T., Sakahara H., Torizuka T., Nakamoto Y., Kanamori S., Hiraoka M., Imamura M., Nishimura Y., Tamaki N., Konishi J.: Evaluation of intraoperative radiation therapy for unresectable pancreatic cancer with FDG PET., J Nucl Med., 40(9):1424-33, 1999 |
|
19 | Fujishiro S., Mitsumori M., Kokubo M., Nagata Y., Sasai K., Kodama H., Hiraoka M.: Evaluation of long-term cosmetic results and complications following breast conseving surgery and radiation therapy for breast cancer., J Jpn. Soc. Ther. Radiol. Oncol. 11: 287-94, 1999 |
|
20 | Shibuya K., Nagata Y., Itoh T., Okajima K., Murata R., Takagi T., Hiraoka M.: Transcatheter arterial infusion therapy in the treatment of advanced pancreatic cancer: a feasibility study., Cardiovasc Intervent Radiol, 22(3): 196-200, 1999 |
|
21 | Ikeda T., Akiyama F., Hiraoka M., Inaji H., Ohuchi N., Takatsuka Y., Yoshimoto M.: Surgical Margin Status as a Cause of Local Failure after Breast Conserving Therapy., Breast Cancer, 6(2): 93-97, 1999 |